MedPath

A randomized trial in cancer-related fatigue in palliatively treated patients: protocolized patient-tailored treatment of physical symptoms (PPT) vs care as usual (CAU)

Phase 3
Completed
Conditions
cancer-related fatigue
10027656
Registration Number
NL-OMON30469
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
152
Inclusion Criteria

a. Histologically or cytologically proven solid malignancy;
b. Curative treatment is not possible anymore;
c. Treated in the outpatient clinic;
d. Presence of fatigue scored as >=4 on a scale of 0 to 10;
e. Age >=18 years;
f. WHO performance status <= 2;
g. Life expectancy >= 3 months;
h. Able to write and speak Dutch;
i. Signed informed consent.

Exclusion Criteria

a. Concomitant (or within 4 weeks before randomization) administration
of any experimental drug;
b. Stay in a nursing home;
c. Untreated depression or anxiety disorders;
d. Severe comorbidity, e.g. heart failure or symptomatic chronic obstructive
lung disease
e. Cognitive limitations

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath